Johnson & Johnson CFO Joe Wolk continues speaking on the company’s Q2 earnings call.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on JNJ:
- Johnson & Johnson Earnings Report: Is it a Beat?
- JNJ Up as Q2 Results Beat Estimates, Raises Outlook
- Genmab reports Q2 worldwide net sales of DARZALEX $2.43B
- Johnson & Johnson intends to ‘split off’ Kenvue shares through an exchange offer
- Johnson & Johnson raises FY23 adjusted EPS to $10.70-$10.80 from $10.60-$10.70